- Home
- EFSC vs RCKT Comparison
EFSC vs RCKT Comparison
Compare EFSC & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EFSC
- RCKT
- Stock Information
- Founded
- EFSC 1988
- RCKT 1999
- Country
- EFSC United States
- RCKT United States
- Employees
- EFSC N/A
- RCKT N/A
- Industry
- EFSC Major Banks
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- EFSC Finance
- RCKT Health Care
- Exchange
- EFSC Nasdaq
- RCKT Nasdaq
- Market Cap
- EFSC 2.0B
- RCKT 1.9B
- IPO Year
- EFSC 1999
- RCKT N/A
- Fundamental
- Price
- EFSC $54.02
- RCKT $17.13
- Analyst Decision
- EFSC Strong Buy
- RCKT Strong Buy
- Analyst Count
- EFSC 4
- RCKT 9
- Target Price
- EFSC $51.75
- RCKT $53.22
- AVG Volume (30 Days)
- EFSC 128.3K
- RCKT 731.3K
- Earning Date
- EFSC 10-21-2024
- RCKT 11-04-2024
- Dividend Yield
- EFSC 2.11%
- RCKT N/A
- EPS Growth
- EFSC N/A
- RCKT N/A
- EPS
- EFSC 4.72
- RCKT N/A
- Revenue
- EFSC $591,631,000.00
- RCKT N/A
- Revenue This Year
- EFSC N/A
- RCKT N/A
- Revenue Next Year
- EFSC $1.49
- RCKT $300.20
- P/E Ratio
- EFSC $11.27
- RCKT N/A
- Revenue Growth
- EFSC N/A
- RCKT N/A
- 52 Week Low
- EFSC $34.26
- RCKT $15.98
- 52 Week High
- EFSC $54.88
- RCKT $32.53
- Technical
- Relative Strength Index (RSI)
- EFSC 61.25
- RCKT 46.41
- Support Level
- EFSC $51.31
- RCKT $17.05
- Resistance Level
- EFSC $53.55
- RCKT $17.75
- Average True Range (ATR)
- EFSC 1.33
- RCKT 0.72
- MACD
- EFSC 0.18
- RCKT 0.06
- Stochastic Oscillator
- EFSC 100.00
- RCKT 40.23
About EFSC Enterprise Financial Services Corporation
Enterprise Financial Services Corporation is a financial holding company. It offers banking and wealth management services to individuals and business customers located in Arizona, California, Florida, Kansas, Missouri, Nevada, and New Mexico, in addition to loan and deposit production offices throughout the United States. The company offers a broad range of business and personal banking services including wealth management services. Lending services include commercial and industrial, commercial real estate, real estate construction and development, residential real estate, and consumer loans.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.